Anti-CXCR4 (phospho S339) antibody
4
(3 Reviews)
|
(28 Publications)
Rabbit Polyclonal CXCR4 phospho S339 antibody. Suitable for IHC-P, ELISA, WB, ICC/IF and reacts with Human, Mouse samples. Cited in 28 publications. Immunogen corresponding to Synthetic Peptide within Human CXCR4 phospho S339.
View Alternative Names
CD184, C-X-C chemokine receptor type 4, CXC-R4, CXCR-4, FB22, Fusin, HM89, LCR1, Leukocyte-derived seven transmembrane domain receptor, Lipopolysaccharide-associated protein 3, NPYRL, Stromal cell-derived factor 1 receptor, LESTR, LAP-3, LPS-associated protein 3, SDF-1 receptor, CXCR4
- ICC/IF
Unknown
Immunocytochemistry/ Immunofluorescence - Anti-CXCR4 (phospho S339) antibody (AB74012)
Immunofluorescence analysis of HeLa cells using ab74012, at 1/500 dilution, in the presence (right panel) or absence (left panel) of the immunising phosphopeptide.
- IHC-P
Unknown
Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-CXCR4 (phospho S339) antibody (AB74012)
Immunohistochemistry analysis of paraffin-embedded human brain carcinoma tissue using ab74012, at 1/50 dilution, in the presence (right panel) or absence (left panel) of the immunising phosphopeptide.
- WB
Unknown
Western blot - Anti-CXCR4 (phospho S339) antibody (AB74012)
All lanes:
Western blot - Anti-CXCR4 (phospho S339) antibody (ab74012) at 1/500 dilution
Lane 1:
Extracts from HUVEC cells treated with etoposide (25uM, 24hours) at 5 µg
Lane 2:
Extracts from HUVEC cells treated with etoposide (25uM, 24hours) at 5 µg with the immunising phosphopeptide
Predicted band size: 39 kDa
Observed band size: 45 kDa
false
Reactivity data
Properties and storage information
Form
Purification technique
Purification notes
Storage buffer
Shipped at conditions
Appropriate short-term storage conditions
Appropriate long-term storage conditions
Aliquoting information
Storage information
Supplementary information
This supplementary information is collated from multiple sources and compiled automatically.
Biological function summary
CXCR4 plays an important role in the immune system hematopoiesis and angiogenesis. It does not function alone and is often part of a larger protein complex where it recruits and activates other G proteins. The receptor mediates chemotactic responses directing cells to sites of inflammation or injury. Its interaction with CXCL12 is critical for maintaining immune surveillance aiding in the movement and positioning of immune cells.
Pathways
CXCR4 integrates into significant cellular signaling pathways such as the PI3K/AKT pathway and the MAPK pathway. It collaborates closely with signaling proteins like AKT1 and MAPK1 impacting cell survival and growth. These pathways are essential for various cellular functions including cell cycle progression and apoptosis regulation. The cross-talk between CXCR4 and these pathways underlines its influence on cell fate decisions.
Product protocols
- Visit the General protocols
- Visit the Troubleshooting
Target data
Publications (28)
Recent publications for all applications. Explore the full list and refine your search
Cancer biology & therapy 26:2471631 PubMed39992057
2025
Applications
Unspecified application
Species
Unspecified reactive species
Cancers 15: PubMed37444550
2023
Applications
Unspecified application
Species
Unspecified reactive species
BMC endocrine disorders 22:292 PubMed36419107
2022
Applications
Unspecified application
Species
Unspecified reactive species
BMC cancer 22:376 PubMed35397601
2022
Applications
Unspecified application
Species
Unspecified reactive species
Molecular neurobiology 58:5421-5436 PubMed33983546
2021
Applications
Unspecified application
Species
Unspecified reactive species
BioMed research international 2021:8883800 PubMed33829065
2021
Applications
Unspecified application
Species
Unspecified reactive species
American journal of translational research 12:2570-2584 PubMed32655791
2020
Applications
Unspecified application
Species
Unspecified reactive species
American journal of physiology. Heart and circulatory physiology 318:H1420-H1435 PubMed32330088
2020
Applications
Unspecified application
Species
Unspecified reactive species
OncoTargets and therapy 13:2899-2910 PubMed32308422
2020
Applications
Unspecified application
Species
Unspecified reactive species
Carcinogenesis 41:817-827 PubMed31430364
2019
Applications
Unspecified application
Species
Unspecified reactive species
Product promise
Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.
For licensing inquiries, please contact partnerships@abcam.com